Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Clinical trial NCT00950417 · COMPLETED

Trial details

NCT number: NCT00950417
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Esophageal

Start date: 2009-07-01
Primary completion: 2010-07-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.